Skip to main content
. Author manuscript; available in PMC: 2018 Jun 1.
Published in final edited form as: Mayo Clin Proc. 2017 Jun;92(6):978–994. doi: 10.1016/j.mayocp.2017.02.011

Table 3.

Decadal changes in aging and disease, Banner Sun Health Research Institute Brain and Body Donation Program/Arizona Study of Aging and Neurodegenerative Disorders.

Decade (n) Mean Control Brain Weight F/M Mean Control MMSE (SD)a Mean Control UPDRS III (SD)b Mean Control CERAD NP Density (SD) Mean Control Braak NFT Stage (SD) % with Infarcts/Mean Total Infarct Volume, cc (SD)c Mean Number of Neuropathological Diagnoses
50s & 60s (112) 1235d/1326 NA NA 0.2 1.3 19/0.5 (2.4) 2.4
70s (311) 1141/1282 28.5 (1.3) 3.9 (2.5) 0.9 (1.1) 2.3 (1.2) 39/7.8 (41) 2.8 (1.3)
80s (595) 1130/1257 28.0 (2.0) 7.8 (7.2) 1.3 (1.2) 3.0 (1.0) 49/10.7 (62) 3.4 (1.4)
90s (259) 1110/1216 27.6 (1.9) 11.2 (6.6) 1.7 (1.2) 3.6 (0.7) 57/12.9 (55) 3.9 (1.6)
100s 1069/NA 25.5 (4.4) 13.5 (10.4) 1.4 (1.5) 3.75 (0.5) 92/5.5 (12) 4.6 (1.3)
a

MMSE score available for 24 (70s), 110 (80s), 69 (90s) and 4 (100s)

b

UPDRS score available for 17 (70s), 101 (80s), 71 (90s) and 4(100s).

c

Any number of acute, subacute or old infarcts were each counted as one diagnosis.

d

Based on n = 3 or less

CERAD=Consortium to Establish a Registry for Alzheimer’s Disease; F/M=Female/Male; MMSE=Minimental Status Exam; NA=not available; NFT=Neurofibrillary Tangle; NP=Neuritic Plaque; SD=Standard Deviation; UPDRS III=Unified Parkinson’s Disease Rating Scale III